OpenVSafe by OpenVAERS
Search V-safe

9BU-20680-36060

5 vaccinations 9 coded responses 57 check-ins 7 free-text entries 3 call cases
Sex
Male
Age at first dose
56-60
ZIP prefix
570 / SD
Registered
2021-04-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-26
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-16
    Dose 2 — Pfizer-BioNTech
  3. 2021-04-18
    Registered in v-safe
  4. 2021-04-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-20
    Survey response — days 1–6 daily, dose 2
    MedDRA: Adrenal insufficiency, Adrenocortical insufficiency acute, Headache, Pre-existing disease — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Systemic reaction (other): secondary adrenal insufficiency that often presents as severe headache · Healthcare visit (other): treated for adrenal crisis with 2L IV fluids and 100mg Solu-Cortef.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-20
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2021-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-04-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  9. 2021-04-23
    Survey response — day 7, dose 2
    MedDRA: Sinusitis — Feeling: Fair · Site: Pain · Headache · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Developed a sinus infection.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-23
    Report sent to call center — day 7, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  11. 2021-04-30
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  12. 2021-05-07
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-05-14
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-05-21
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-05-28
    Survey response — day 42, dose 2
    MedDRA: Sinusitis — Feeling: Good
    Free text: Seem to be getting another sinus infection. (I got one about a week after my 2nd shot.) Odd for me to get another so soon, but allergens are terrible right now.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-07-16
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  17. 2021-10-15
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-10-29
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  19. 2021-10-29
    Survey response — day 0, dose 3
    MedDRA: Pain in extremity — Feeling: Good
    Free text: Some pain from flu shot in other arm. No pain from COVID shot.
    MedDRA releases: 2024-11 · check-in free text available
  20. 2021-10-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  21. 2021-10-31
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  22. 2021-11-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend school
    Adult check-in
  23. 2021-11-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  24. 2021-11-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  25. 2021-11-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  26. 2021-11-05
    Health check-in — day 7, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  27. 2021-11-12
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  28. 2021-11-19
    Survey response — day 21, dose 3
    MedDRA: Sinusitis — Feeling: Fair
    Free text: Sinus infection.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-11-26
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  30. 2021-12-03
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-12-10
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  32. 2022-01-28
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  33. 2022-04-05
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  34. 2022-04-05
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  35. 2022-04-29
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  36. 2022-05-05
    Dose 4 — Pfizer-BioNTech
  37. 2022-05-05
    Survey response — day 0, dose 4
    MedDRA: Anxiety — Feeling: Good · Muscle or body aches
    Free text: Anxiety
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-05-06
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  39. 2022-05-07
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  40. 2022-05-08
    Health check-in — days 1–6 daily, dose 4
    Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  41. 2022-05-09
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  42. 2022-05-10
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  43. 2022-05-11
    Health check-in — days 1–6 daily, dose 4
    Feeling: Poor · Headache, Fatigue or tiredness
    Adult check-in
  44. 2022-05-12
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  45. 2022-05-19
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  46. 2022-05-26
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  47. 2022-06-02
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  48. 2022-06-09
    Health check-in — day 35, dose 4
    Feeling: Fair
    Adult check-in
  49. 2022-06-16
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  50. 2022-08-04
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  51. 2022-11-03
    Health check-in — 6 months, dose 4
    Feeling: Fair
    Adult check-in
  52. 2022-11-28
    Dose 5 — Pfizer-BioNTech
  53. 2022-11-28
    Health check-in — day 0, dose 5
    Feeling: Good · Site: Pain · None
    Adult check-in
  54. 2022-11-29
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  55. 2022-11-30
    Survey response — days 1–6 daily, dose 5
    MedDRA: Inflammation — Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Inflammation
    MedDRA releases: 2024-11 · check-in free text available
  56. 2022-12-01
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Headache
    Adult check-in
  57. 2022-12-02
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  58. 2022-12-03
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  59. 2022-12-04
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Headache
    Adult check-in
  60. 2022-12-05
    Health check-in — day 7, dose 5
    Feeling: Good · None
    Adult check-in
  61. 2022-12-12
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  62. 2022-12-19
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  63. 2022-12-26
    Health check-in — day 28, dose 5
    Feeling: Fair
    Adult check-in
  64. 2023-01-02
    Survey response — day 35, dose 5
    MedDRA: Sinusitis — Feeling: Fair · Be unable to do your normal daily activities
    MedDRA releases: 2024-11
  65. 2023-01-09
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  66. 2023-02-27
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in
  67. 2023-05-30
    Survey response — 6 months, dose 5
    MedDRA: Basal cell carcinoma — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  68. 2023-05-30
    Call case (no matching report) — Successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  69. 2023-05-31
  70. 2023-05-31
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-03-26Pfizer-BioNTech
22021-04-16Pfizer-BioNTech
32021-10-29Pfizer-BioNTech Flu
42022-05-05Pfizer-BioNTech No
52022-11-28Pfizer-BioNTech No

Call center

3 call center cases

3 successful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-20

Systemic reaction (other): secondary adrenal insufficiency that often presents as severe headache
Healthcare visit (other): treated for adrenal crisis with 2L IV fluids and 100mg Solu-Cortef.

Release 7 — day 7, dose 2

2021-04-23

Systemic reaction (other): Developed a sinus infection.

Release 8 — day 42, dose 2

2021-05-28

Symptoms: Seem to be getting another sinus infection. (I got one about a week after my 2nd shot.) Odd for me to get another so soon, but allergens are terrible right now.

Release 10 — day 0, dose 3

2021-10-29

Systemic reaction (other): Some pain from flu shot in other arm. No pain from COVID shot.

Release 10 — day 21, dose 3

2021-11-19

Symptoms: Sinus infection.

Release 11 — day 0, dose 4

2022-05-05

Systemic reaction (other): Anxiety

Release 12 — days 1–6 daily, dose 5

2022-11-30

Systemic reaction (other): Inflammation

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOAdrenocortical insufficiency acute ✓ ✓ ✓
SDBasal cell carcinoma · · ✓
SDSinusitis ✓ ✓ ✓
SROAdrenal insufficiency ✓ ✓ ✓
SROAnxiety · · ✓
SROHeadache ✓ ✓ ✓
SROInflammation · · ✓
SROPain in extremity · · ✓
SROPre-existing disease ✓ ✓ ✓
SROSinusitis ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release